Previous close | 79.94 |
Open | 80.02 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 79.93 - 80.11 |
52-week range | 56.86 - 86.44 |
Volume | |
Avg. volume | 1,910 |
Market cap | 320.432M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 1.07 |
EPS (TTM) | 0.75 |
Earnings date | 07 Aug 2023 - 11 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Welltower (WELL) raises the midpoint of its 2023 normalized FFO per share guidance backed by the continued strength in the seniors housing operating portfolio and recent capital activity.
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Improving SHO portfolio fundamentals, portfolio restructuring initiatives and capital recycling efforts drive Welltower's (WELL) shares 10.5% up in the past six months.
Welltower's (WELL) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company raises its 2023 FFO per share outlook.
While the top- and bottom-line numbers for Welltower (WELL) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Shares of Welltower (NYSE: WELL) jumped 10.5% in April, according to data provided by S&P Global Market Intelligence. Analyst upgrades were the primary catalyst driving shares of the healthcare REIT higher last month. Several analysts adjusted their ratings and price targets on Welltower last month.
Welltower's (WELL) Q1 earnings are likely to have benefited from the positive operating trends in the seniors housing operating portfolio.
Improving operating fundamentals of its tenants are likely to have aided Medical Properties' (MPW) Q1 earnings. However, higher interest expenses and exposure to troubled operators might have ailed.
Block shares are making headlines for all the wrong reasons today, with short-seller Hindenburg Research raising red flags surrounding the company. Whose side are you on?
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
Welltower and Ventas got hammered during the pandemic because of their senior housing assets. That's changing in a big way.
Welltower's (WELL) Q4 results gain on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company issues its 2023 outlook.
Welltower (WELL) delivered FFO and revenue surprises of 1.22% and 1.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Positive operating trends in the SHO portfolio are likely to have aided Welltower's (WELL) Q4 earnings. However, rising interest rates and a stronger U.S. dollar might have been a spoilsport.
Welltower's (WELL) diversified portfolio of healthcare assets, strategic repositioning efforts and strong balance sheet bode well. Stiff competition and rising interest rates are key concerns.
Welltower Inc. ( NYSE:WELL ) shareholders should be happy to see the share price up 20% in the last quarter. In...
Welltower's (WELL) restructuring initiatives, improving seniors housing operating portfolio fundamentals and capital recycling efforts drive a 15% increase in its share price.
Welltower (WELL) enters a master lease with Integra for the entire 147-property skilled nursing portfolio. It also sells 15% interest in 54 skilled nursing assets to Integra for $73 million.
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
It's time to be extra picky.
Welltower ( NYSE:WELL ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.47b (up 19% from 3Q 2021). Funds...
Tuesday was a good day to be an investor in specialty real estate investment trust (REIT) Welltower (NYSE: WELL). Welltower's third quarter saw it earn just over $1.47 billion in revenue, which represented growth of almost 19% on a year-over-year basis. Concurrently, Welltower announced that it reached agreement with its partner ProMedica to sell 147 skilled nursing facilities currently operated by the latter.
Welltower (WELL) reports healthy Q3 results, with the top line growing year over year. The SHO portfolio witnesses improvement in occupancy. WELL's total same-store NOI increases year over year.